AT1 Receptor as a Potential Target in Amphetamine-induced Neuroinflammation-Reference-Cited by-同舟云学术

AT1 Receptor as a Potential Target in Amphetamine-induced Neuroinflammation

Published:2022-05 Issue:5 Volume:29 Page:371-374
ISSN:0929-8665
Container-title:Protein & Peptide Letters
language:en
Short-container-title:PPL

Author:

Cabrera Ricardo Jorge¹,Baiardi Lucia²,Bregonzio Claudia²^ORCID

Affiliation:

1. Instituto de Investigaciones Biomédicas (INBIOMED), Universidad de Mendoza, IMBECU–CONICET, Paseo Dr. Emilio Descotte 720, 5500 Mendoza, Argentina

2. Instituto de Farmacología Experimental Córdoba (IFEC-CONICET), Departamento de Farmacología. Facultad de Ciencias Químicas Universidad Nacional de Córdoba, Córdoba, Argentina

Abstract

Funder

Agencia Nacional de Promoción Científica y Tecnológica

Publisher

Bentham Science Publishers Ltd.

Subject

Biochemistry,General Medicine,Structural Biology

Reference31 articles.

1. Ransohoff R.M.; Brown M.A.; Innate immunity in the central nervous system. J Clin Invest 2012,122(4),1164-1171

2. Yang Q.Q.; Zhou J.W.; Neuroinflammation in the central nervous system: Symphony of glial cells. Glia 2019,67(6),1017-1035

3. Steinkellner T.; Freissmuth M.; Sitte H.H.; Montgomery T.; The ugly side of amphetamines: Short- and long-term toxicity of 3,4-methylenedioxymethamphetamine (MDMA, ‘Ecstasy’), metham-phetamine and D-amphetamine. Biol Chem 2011,392(1-2),103-115

4. Levi M.S.; Divine B.; Hanig J.P.; Doerge D.R.; Vanlandingham M.M.; George N.I.; Twaddle N.C.; Bowyer J.F.; A comparison of methylphenidate-, amphetamine-, and methamphetamine-induced hyperthermia and neurotoxicity in male Sprague-Dawley rats during the waking (lights off) cycle. Neurotoxicol Teratol 2012,34(2),253-262

5. Ricaurte G.A.; Mechan A.O.; Yuan J.; Hatzidimitriou G.; Xie T.; Mayne A.H.; McCann U.D.; Amphetamine treatment similar to that used in the treatment of adult attention-deficit/hyperactivity disorder damages dopaminergic nerve endings in the striatum of adult nonhuman primates. J Pharmacol Exp Ther 2005,315(1),91-98